BioCentury
ARTICLE | Company News

Panacea Pharmaceuticals, SRL Inc. deal

December 22, 2003 8:00 AM UTC

Panacea granted SRL nonexclusive rights in Japan to develop cancer diagnostics based on Panacea's HAAH Oncology Program. The program targets the enzyme human aspartyl (asparaginyl) beta-hydroxylase ...